Company Number: 15208677

Analysis Date: 2025-07-29 15:05 UTC

Financial Health Assessment for MAMINV LIMITED

---

1. Financial Health Score: D

Explanation:
MAMINV LIMITED is a very young company, incorporated in October 2023, with its first accounting period ending October 2024. The financial data available shows extremely limited activity and resources, with total net current assets and shareholders' funds of only £100. Given the minimal asset base, no revenue or profit data, and no liabilities, the financial "vital signs" indicate a company in the earliest startup phase without operational scale or financial robustness. This warrants a cautious grade of D, reflecting initial establishment rather than operational health.

---

2. Key Vital Signs

Metric	Value	Interpretation
Current Assets	£100	Very low cash or short-term resources; "healthy cash flow" not yet evident.
Net Current Assets	£100	Positive working capital but at a negligible level; no signs of financial stress at this point.
Total Assets Less Current Liabilities	£100	Minimal asset base; liabilities effectively zero, so no immediate "symptoms of distress".
Shareholders’ Funds	£100	Entire equity base is nominal; the company is at inception with limited capital invested.
Employees	1 (average)	Small micro-entity with minimal human resources, suitable for startup phase.
Audit Status	Exempt	Micro-entity exemption reflects small scale and minimal compliance burden at this stage.

---

3. Diagnosis

MAMINV LIMITED is in the very early phase of its lifecycle, with financial data characteristic of a micro-entity startup. The balance sheet shows nominal assets and equity, indicating the company has just begun operations or is in the preparatory stage of its building development activities (SIC 41100). The absence of liabilities or expenses suggests no financial distress, but also no operational activity or income generation yet. The company’s financial health is not yet established; it is too early for signs of profitability, cash flow stability, or asset growth.

The "symptoms" at this stage are typical for a newly incorporated company: minimal financial activity, limited capital, and a single employee (likely the director). The financial statements are unaudited, consistent with the micro-entity status, and comply with small company provisions.

---

4. Recommendations

• Capital Injection: To strengthen the financial backbone, consider additional equity or funding to support initial operational expenses and asset acquisition, which will help build a "healthy cash flow" and working capital buffer.
• Revenue Generation Focus: Accelerate efforts to secure contracts or projects that generate turnover, transitioning from startup to operational entity with measurable income and profit.
• Financial Controls: Even at this early stage, implement basic accounting and cash flow monitoring to detect any early "symptoms of distress" such as cash shortages or mounting payables.
• Compliance and Reporting: Maintain timely filing of accounts and confirmation statements to avoid penalties and maintain transparency with stakeholders.
• Growth Planning: Develop a formal business plan outlining milestones and financial projections to guide the company through its critical early growth phase.

---